Lyell Immunopharma, Inc. - LYEL
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$372.4M
QoQ value delta ($000)
+$224.7M
(+152.01%)
Implied price effect (QoQ)
+92.24%
Shares
Total shares
12,125,777
QoQ shares delta
+2,875,774
(+31.09%)
Total shares held by funds (by quarter)
Market chart (LYEL)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| ARCH Venture Management, LLC | 84,924 | 2,759,072 | 13.03% |
| GSK plc | 46,559 | 1,512,659 | 5.83% |
| MWG Caph Ltd | 31,029 | 1,008,116 | 42.88% |
| VANGUARD GROUP INC | 25,437 | 826,430 | 0.0% |
| Foresite Capital Management IV, LLC | 24,636 | 800,399 | 10.72% |
| Orland Properties Ltd | 23,229 | 754,698 | 4.35% |
| Decheng Capital LLC | 21,301 | 692,050 | 2.87% |
| Almitas Capital LLC | 17,784 | 577,807 | 3.92% |
| Foresite Capital Management V, LLC | 14,684 | 477,078 | 8.93% |
| CITADEL ADVISORS LLC | 10,486 | 340,701 | 0.0% |
| venBio Partners LLC | 10,394 | 337,697 | 4.81% |
| Alphabet Inc. | 9,026 | 293,256 | 0.35% |
| BlackRock, Inc. | 5,596 | 181,837 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 5,019 | 162,997 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 4,906 | 159,416 | 0.0% |
| HSG Holding Ltd | 3,935 | 152,299 | 0.21% |
| Invesco Ltd. | 3,036 | 98,649 | 0.0% |
| GOLDMAN SACHS GROUP INC | 2,975 | 96,675 | 0.0% |
| MIC Capital Management UK LLP | 2,678 | 87,028 | 0.61% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,629 | 85,423 | 0.0% |
| RBF Capital, LLC | 2,295 | 74,585 | 0.1% |
| MARSHALL WACE, LLP | 2,256 | 73,315 | 0.0% |
| MILLENNIUM MANAGEMENT LLC | 1,805 | 58,651 | 0.0% |
| JOHNSON & JOHNSON | 1,689 | 54,887 | 0.3% |
| STATE STREET CORP | 1,584 | 51,472 | 0.0% |